Palvella Therapeutics, Inc. SEC filings PVLA

Palvella Therapeutics, Inc. has 814 filings in SEC EDGAR's recent list, going back to Aug 20, 2013. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (other events). The company's fiscal year ends on December 31.

Palvella Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 28, 2026 Oct 28, 2026
S-8 Employee stock plan registration Aug 4, 2026 —
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 4, 2026 Aug 4, 2026
8-K Current report
Other events
Jul 14, 2026 Jul 14, 2026
8-K Current report
Officer or director change
Jun 30, 2026 Jun 29, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 16, 2026 Jun 10, 2026
8-K Current report
Other events
May 20, 2026 May 20, 2026
8-K Current report
Other events
May 15, 2026 May 15, 2026
8-K Current report
Other events
May 13, 2026 May 11, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 10, 2026
8-K Current report
Officer or director change
Apr 13, 2026 Apr 13, 2026
8-K Current report
Other events
Apr 7, 2026 Apr 7, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 31, 2026 Mar 31, 2026
8-K Current report
Material agreement
Feb 26, 2026 Feb 25, 2026
424B5 Prospectus supplement Feb 26, 2026 —
424B5 Prospectus supplement Feb 24, 2026 —
8-K Current report
Results of operations
Feb 24, 2026 Feb 24, 2026
8-K Current report
Regulation FD disclosure
Feb 24, 2026 Feb 24, 2026
8-K Current report
Other events
Feb 24, 2026 Feb 24, 2026
EFFECT Filing Jan 29, 2026 —
8-K Current report
Other events
Jan 29, 2026 Jan 29, 2026
CORRESP Letter to the SEC Jan 27, 2026 —
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
UPLOAD Letter from the SEC Jan 5, 2026 —
S-3 Shelf registration Jan 2, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Dec 15, 2025 Dec 15, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2025 Nov 10, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 5, 2025 Nov 5, 2025
8-K Current report
Regulation FD disclosure
Sep 24, 2025 Sep 24, 2025
8-K Current report
Regulation FD disclosure
Sep 3, 2025 Sep 3, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2025 Aug 14, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 10, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2025 May 15, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 10, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 31, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
Mar 4, 2025 Mar 4, 2025
S-8 Employee stock plan registration Feb 18, 2025 —
424B3 Prospectus Jan 17, 2025 —
EFFECT Filing Jan 16, 2025 —
CORRESP Letter to the SEC Jan 15, 2025 —
S-1/A Amended registration statement Jan 14, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
UPLOAD Letter from the SEC Jan 3, 2025 —
S-1 Registration statement Dec 31, 2024 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
Dec 16, 2024 Dec 13, 2024
425 Form 425 Dec 12, 2024 —
8-K Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
Dec 12, 2024 Dec 11, 2024
425 Form 425 Dec 3, 2024 —
8-K Current report
Shareholder vote results, Other events
Dec 3, 2024 Dec 2, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
SEC STAFF LETTER Filing Nov 12, 2024 —
EFFECT Filing Nov 8, 2024 —
424B3 Prospectus Nov 8, 2024 —
425 Form 425 Nov 7, 2024 —
CORRESP Letter to the SEC Nov 7, 2024 —
S-4/A Form s-4/a Nov 7, 2024 —
DEF 14A Proxy statement Nov 6, 2024 Dec 2, 2024
ARS Annual report to shareholders Nov 6, 2024 Dec 31, 2023
CORRESP Letter to the SEC Nov 5, 2024 —
S-4/A Form s-4/a Nov 5, 2024 —
UPLOAD Letter from the SEC Nov 4, 2024 —
CORRESP Letter to the SEC Oct 29, 2024 —
S-4/A Form s-4/a Oct 29, 2024 —
SEC STAFF LETTER Filing Oct 25, 2024 —
UPLOAD Letter from the SEC Oct 25, 2024 —
425 Form 425 Oct 17, 2024 —
CORRESP Letter to the SEC Oct 15, 2024 —
S-4/A Form s-4/a Oct 15, 2024 —
425 Form 425 Oct 15, 2024 —
UPLOAD Letter from the SEC Oct 9, 2024 —
425 Form 425 Oct 3, 2024 —
8-K Current report
Other events
Oct 3, 2024 Oct 3, 2024
CORRESP Letter to the SEC Sep 23, 2024 —
S-4/A Form s-4/a Sep 23, 2024 —
UPLOAD Letter from the SEC Sep 6, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
S-4 Registration for a merger or exchange Aug 9, 2024 —
425 Form 425 Aug 8, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Aug 8, 2024 Aug 7, 2024
425 Form 425 Jul 24, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Jul 24, 2024 Jul 23, 2024
8-K Current report
Agreement ended, Other events
Jul 3, 2024 Jun 28, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Other events
May 9, 2024 May 7, 2024
10-K/A Amended annual report Apr 29, 2024 Dec 31, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Apr 18, 2024 Apr 18, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
8-K Current report
Results of operations, Other events
Mar 27, 2024 Mar 27, 2024
8-K Current report
Agreement ended
Dec 21, 2023 Dec 15, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K/A Amended current report
Exit or restructuring costs
Aug 31, 2023 Jul 17, 2023
S-8 Employee stock plan registration Aug 10, 2023 —
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Agreement ended, Results of operations, Exit or restructuring costs, Other events
Jul 18, 2023 Jul 17, 2023
8-K Current report
Officer or director change
Jul 13, 2023 Jul 13, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 26, 2023 Jun 21, 2023
8-K Current report
Results of operations, Other events
Jun 21, 2023 Jun 21, 2023
8-K Current report
Regulation FD disclosure
Jun 8, 2023 Jun 8, 2023
8-K Current report
Listing notice
May 19, 2023 May 15, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2023 May 10, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 21, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 29, 2023 Mar 29, 2023
8-K Current report
Regulation FD disclosure
Jan 10, 2023 Jan 10, 2023
CT ORDER Filing Jan 3, 2023 —
CT ORDER Filing Jan 3, 2023 —
CT ORDER Filing Jan 3, 2023 —
CT ORDER Filing Dec 16, 2022 —
424B5 Prospectus supplement Nov 4, 2022 —
8-K Current report
Material agreement
Nov 4, 2022 Nov 4, 2022
10-Q Quarterly report Nov 4, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2022 Nov 2, 2022
8-K Current report
Regulation FD disclosure
Nov 1, 2022 Nov 1, 2022
8-K Current report
Regulation FD disclosure
Sep 13, 2022 Sep 13, 2022
S-8 Employee stock plan registration Aug 4, 2022 —
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Aug 4, 2022 Aug 4, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 4, 2022 Aug 4, 2022
10-K/A Amended annual report Jul 6, 2022 Dec 31, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 27, 2022 Jun 22, 2022
8-K Current report
Regulation FD disclosure
Jun 8, 2022 Jun 8, 2022
8-K Current report
Regulation FD disclosure
May 25, 2022 May 25, 2022
8-K/A Amended current report
Regulation FD disclosure
May 12, 2022 May 11, 2022
10-Q Quarterly report May 11, 2022 Mar 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 11, 2022 May 11, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 22, 2022
10-K Annual report Mar 2, 2022 Dec 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Mar 1, 2022 Mar 1, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jan 24, 2022 Jan 24, 2022
8-K Current report
Regulation FD disclosure
Jan 14, 2022 Jan 14, 2022
8-K/A Amended current report
Regulation FD disclosure
Jan 14, 2022 Nov 18, 2021
8-K Current report
Other events
Jan 3, 2022 Jan 3, 2022
8-K Current report
Regulation FD disclosure
Nov 18, 2021 Nov 18, 2021
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
8-K Current report
Officer or director change, Other events
Oct 6, 2021 Oct 6, 2021
8-K Current report
Regulation FD disclosure
Aug 30, 2021 Aug 27, 2021
8-K Current report
Regulation FD disclosure, Other events
Aug 24, 2021 Aug 24, 2021
EFFECT Filing Aug 13, 2021 —
CORRESP Letter to the SEC Aug 11, 2021 —
UPLOAD Letter from the SEC Aug 11, 2021 —
S-8 Employee stock plan registration Aug 5, 2021 —
S-3 Shelf registration Aug 5, 2021 —
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Aug 4, 2021 Aug 4, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 29, 2021 Jun 25, 2021
8-K Current report
Regulation FD disclosure
Jun 25, 2021 Jun 25, 2021
424B3 Prospectus Jun 1, 2021 —
EFFECT Filing May 28, 2021 —
CORRESP Letter to the SEC May 26, 2021 —
8-K Current report
Regulation FD disclosure
May 25, 2021 May 25, 2021
8-K Current report
Material agreement
May 25, 2021 May 19, 2021
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
May 21, 2021 May 20, 2021
UPLOAD Letter from the SEC May 19, 2021 —
S-3 Shelf registration May 17, 2021 —
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 17, 2021 May 17, 2021
DEFA14A Additional proxy material Apr 29, 2021 —
DEF 14A Proxy statement Apr 29, 2021 Jun 25, 2021
8-K Current report
Material agreement
Apr 26, 2021 Apr 24, 2021
8-K Current report
Regulation FD disclosure
Apr 12, 2021 Apr 10, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Mar 30, 2021 Mar 30, 2021
8-K Current report
Material agreement, Unregistered share sale
Mar 30, 2021 Mar 29, 2021
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 25, 2021 Mar 24, 2021
8-K Current report
Regulation FD disclosure
Dec 15, 2020 Dec 15, 2020
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 4, 2020 Nov 4, 2020
8-K Current report
Regulation FD disclosure
Sep 21, 2020 Sep 21, 2020
8-K Current report
Regulation FD disclosure
Sep 21, 2020 Sep 19, 2020
8-K Current report
Regulation FD disclosure
Sep 9, 2020 Sep 9, 2020
S-8 Employee stock plan registration Aug 10, 2020 —
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
8-K Current report
Material agreement
Aug 10, 2020 Aug 10, 2020
CT ORDER Filing Aug 7, 2020 —
8-K Current report
Other events
Jul 20, 2020 Jul 20, 2020
8-K Current report
Officer or director change, Shareholder vote results
Jun 29, 2020 Jun 23, 2020
DEFA14A Additional proxy material Jun 8, 2020 —
8-K Current report
Other events
Jun 8, 2020 Jun 8, 2020
8-K Current report
Regulation FD disclosure
Jun 4, 2020 Jun 4, 2020
8-K Current report
Regulation FD disclosure
May 21, 2020 May 21, 2020
CT ORDER Filing May 12, 2020 —
10-Q Quarterly report May 11, 2020 Mar 31, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PVLA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Wayne, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1583648
Former names
PIERIS PHARMACEUTICALS, INC. (until Dec 12, 2024); Marika Inc. (until Dec 18, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.